Johns Hopkins epidemiologist David Dowdy says vaccines and a preventive drug for RSV offer hope for a healthier fall and winter| The Hub
Vaccine expert Ruth Karron discusses the authorization of COVID-19 vaccines for those under 5 years old, and what's likely to happen with the authorization over the next few weeks| The Hub
Easy to manufacture and update, these new vaccines may be a powerful tool against emerging variants and other infectious diseases| The Hub
Three Johns Hopkins experts discuss the potential of mRNA-powered therapeutics to produce lifesaving treatments and cures for a range of diseases, and why federal research cuts risk undermining U.S. scientific leadership in this emerging area| The Hub
Q+A| The Hub
New analysis predicts locations for possible future U.S. outbreaks based on international air travel, vaccination rates, population data| The Hub